Belinostat CAS: 414864-00-9
MF: C15H14N2O4S
MW: 318.35
A novel HDAC inhibitor.

Belinostat (CAS 414864-00-9)

Belinostat | CAS 414864-00-9 is rated 5.0 out of 5 by 1.
  • y_2022, m_1, d_23, h_20
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.20
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_269851, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 105ms
  • REVIEWS, PRODUCT
loading
5
1
4
0
3
0
2
0
1
0
Alternate Names: (2E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]acrylamide
Application: Belinostat is a novel HDAC inhibitor
CAS Number: 414864-00-9
Molecular Weight: 318.35
Molecular Formula: C15H14N2O4S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data (including water content).
loading

Belinostat (PXD101) is a novel HDAC (histone deacetylase) inhibitor with IC50 of 27 nM. Belinostat inhibits the growth of tumor cells (A2780, HCT116, HT29, WIL, CALU-3, MCF7, PC3 and HS852) with IC50 from 0.2-0.66 μM. PD101 shows low activity in A2780/cp70 and 2780AD cells. Belinostat inhibits bladder cancer cell growth, especially in 5637 cells, which shows accumulation of G0-G1 phase, decrease in S phase, and increase in G2-M phase. Belinostat also shows enhanced tubulin acetylation in ovarian cancer cell lines. A recent study shows that Belinostat activates PKA (protein kinase A) in a TGF-β signaling-dependent mechanism and decreases survivin mRNA. Belinostat is an inhibitor of HDAC3 (histone deacetylase 3).

Physical State :
Solid
Storage :
Store at -20° C
Melting Point :
241.16° C (Predicted)
Density :
~1.4 g/cm3 (Predicted)
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
PubChem CID :
SMILES :
C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)/C=C/C(=O)NO

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 94ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of 5 by from Belinostat was reported as an anticancer Belinostat was reported as an anticancer agent and an inhibitor of HDAC3, in many articles. -SCBT Publication Review
Date published: 2015-03-18
  • y_2022, m_1, d_23, h_20
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.20
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_269851, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 7ms
  • REVIEWS, PRODUCT